Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
nVNS in Opioid Use Disorders
NCT04556552Phase 3Completed
- Sponsor
- Emory University
- Start
- Nov 2020
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by Emory University. Primary endpoints: Opioid Craving Using Visual Analogue Scale, Heart Rate (HR) and 3 more. Started Nov 2020; status: completed.
Beyond the preview
Go deeper on NCT04556552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04556552.